A-Z Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ALL
Instagram Facebook Twitter Youtube
Reporting LAHAN Alerts
Banner

COVID-19 Vaccine

Healthcare Provider Information Hub


New and Noteworthy - COVID-19 Vaccination

Information about the COVID-19 vaccination program is changing frequently. Please check this site often and be sure to refresh your browser to view updates.

  • CDC Updated Booster Eligibility and Recommendations (1-7-22) The CDC updated the Interim Clinical Considerations for the Use of COVID-19 Vaccines on 1-6-22. Included in these updates are that adolescents age 12-15 should receive a Pfizer booster dose after their initial Pfizer primary vaccination series and that moderately and severely immunocompromised 5-11-year-olds should receive a third primary dose of vaccine 28 days after their second shot. In addition, people who received an mRNA COVID-19 vaccine (Moderna or Pfizer) as their primary series can now receive an mRNA booster after 5 months.. The following LAC DPH resources have been updated to reflect these recommendations:

Upcoming webinars and trainings

  • CDC COVID-19 Vaccine Webinar Series (with CE) brief (15-20 minute) interactive modules that offer a real-world perspective on issues such as clinical and vaccine safety information, guidance for on-site clinic vaccination, and having conversations with vaccine recipients. Webinars
  • CDC Vaccine Training Modules (with CE) – new Janssen module. Modules include a general overview of immunization practices, and Janssen, Pfizer and Moderna vaccine storage, handling, preparation, administration, and documentation. Modules

Standing webinars

  • CDC COCA Webinars: Clinician Outreach and Communication Activity (COCA) Past COVID-19 topics include underlying medical conditions and severe COVID-19, vaccine safety and efficacy, and treating long COVID. Recorded webinars | Subscribe.
  • CDC/IDSA COVID-19 Clinician Calls: Alternate Saturdays 12-1pm PST. Past webinars include post-COVID conditions, variants, vaccination, and COVID-19 outcomes in at-risk groups. Recorded webinars | Subscribe.
  • AMA COVID-19 webinar series - What Physicians Need to Know: Live and archived webinars on COVID-19 vaccine and therapeutics Webinars

View recorded webinars

Becoming a COVID-19 Vaccination Provider

DPH greatly appreciates the partnership of health care providers and organizations to administer the COVID-19 vaccine to their patient population and their surrounding community members. If you are interested in becoming a vaccination provider, visit the Vaccination Partner Checklist to review all the requirements and additional information.

Detailed information regarding enrollment processes for joining the California COVID-19 Vaccination Program can be found at the CDPH EZIZ website at: https://eziz.org/covid/enrollment/.

Information & Resources for Patients

DPH Resources

  • Vaccine General Resources website hosts frequently asked questions, fact sheets, and many other vaccine-related resources for patients and the public in multiple language.

CDPH Resources

  • Vaccine Benefits and Risks Fact Sheets one-page summaries of the FDA EUA fact sheets
  • Minor Consent for Pfizer vaccine guidance for providers and the public and template consent form

CDC Resources - Answering patients’ questions about COVID-19 vaccine:

  • Educating Vaccine Recipients webpage: This webpage and its subpages provide information about and resources for educating your patients about COVID-19 vaccines.
  • Patient FAQs

FDA Resources

Recorded Webinars

  • CDC COCA Call: Updated Guidance for Clinicians on COVID-19 Vaccines (12-including the latest evidence on thrombosis with thrombocytopenia syndrome (TTS) after receipt of the J&J vaccine. Slides and recording
  • VRBPAC (10-26-21) Voted to recommend that the EUA for the Pfizer-BioNTech COVID-19 vaccine be expanded for use in children aged 5-11. Meeting notes and recording
  • CDC COCA Call on Pediatric COVID-19 Vaccines recording and slides
  • ACIP Meeting. Booster doses, effectiveness, and pregnancy (9-22-21 and 9-23-21) Slides
  • CDC/IDSA COVID-19 Clinician Call: Vaccine Boosters and Q&A with CDC’s Vaccine Task Force This call will include discussions of immune response and COVID-19, perspectives from the Vaccines and Related Biological Products Advisory Committee, and ACIP recommendations and clinical considerations. Date and time: 9-25-21 at 12pm PT. Recording
  • CDC COCA Call: What Clinicians Need to Know About the Latest CDC Recommendations for Pfizer-BioNTech COVID-19 Booster Vaccination Clinicians will learn about the vaccine booster recommendations, safety of booster dose, and clinical guidance for using the Pfizer-BioNTech COVID-19 booster vaccine. No registration required. Date and time: 9-28-21 at 11am-12pm PT. More info Slides
  • CDC/IDSA COVID-19 Clinician Call: Vaccine Boosters and Q&A with CDC’s Vaccine Task Force (9-25-21) Includes information on immune response and COVID-19 and vaccination, perspectives from the Vaccines and Related Biological Products Advisory Committee, and ACIP recommendations and clinical considerations. Recording | Slides
  • CDC COCA Call: Influenza vaccination and coadministration with COVID-19 vaccines (9-9-21) ACIP recommendations for 2021-2022 influenza vaccination and guidance for coadministration of these vaccines and COVID-19 vaccines. Free CME. Recording and Slides
  • CDC COCA Call - Additional mRNA COVID-19 Vaccines for Moderately to Severely Immunocompromised People (8-17-21) Recording and Slides
View upcoming webinars

Contact us about Vaccines

Vaccine Administration Provider Line -Questions about vaccine distribution, storage and handling, and guidance on registering to receive the vaccine through the CDPH enrollment website.

Vaccine Clinical Provider Line –Clinical questions about COVID-19 vaccines including but not limited to contraindications, precautions, side effects, post vaccination assessment

  • Monday through Friday, 8:00am-5:00pm, call 213-240-7941. For time-sensitive questions after hours, call 213-974-1234 and ask for the on-call clinician

CDC/CISAvax (Clinical Immunization Safety Assessment Project) - Consults about COVID-19 vaccine safety. Healthcare providers can request a consultation from CISA COVIDvax for a complex COVID-19 vaccine safety question that is (1) about an individual patient residing in the United States or vaccine safety issue and (2) not readily addressed by CDC or Advisory Committee on Immunization Practices (ACIP) guidelines. CISA has vaccine safety subject matter experts in multiple specialties (e.g. ID, allergy/immunology, neurology, OB/GYN, pediatrics, geriatrics)

  • Contact CDC_INFO: 800-CDC-INFO (800-232-4636) or online
  • In case of an emergent clinical COVID-19 vaccine safety inquiry, healthcare providers can call the CDC Emergency Operations Center (EOC) Watch Desk at (770)-488-7100. The EOC Watch Desk will route emergency inquiries to the CISA COVIDvax on-call staff.

Medical professionals interested in supporting the COVID-19 response:


Icon: Get Adobe Reader
Adobe Reader

Note: PDF documents on this site were created using Adobe Acrobat 5.0 or later. Document functionality may be reduced if you are using an earlier version (4.x or less). Get the latest version of Adobe Acrobat.

  • Home  |
  • Careers  |
  • DPH Programs  |
  • Email: Webmaster  |
  • Notice of Privacy Practices | 
  • Website Privacy Policy  |
  • Accessibility  |
  • Disclaimer  |
  • Employee


  • Public Health has made reasonable efforts to provide accurate translation. However, no computerized translation is perfect and is not intended to replace traditional translation methods. If questions arise concerning the accuracy of the information, please refer to the English edition of the website, which is the official version.

    Los Angeles County Seal: Enriching lives through effective and caring services